The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).
 
Loic Lebellec
No Relationships to Disclose
 
Axel Le Cesne
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer (Inst); PharmaMar (Inst); Roche/Genentech (Inst)
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst)
 
Christine Chevreau
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Didier Cupissol
No Relationships to Disclose
 
Michel Fabbro
Travel, Accommodations, Expenses - Roche
 
Esma Saada
No Relationships to Disclose
 
Florence Duffaud
No Relationships to Disclose
 
Loic Feuvret
No Relationships to Disclose
 
Alice Bonneville-Levard
No Relationships to Disclose
 
Jacques-Olivier Bay
No Relationships to Disclose
 
Elodie Vauleon
No Relationships to Disclose
 
Georges Noel
No Relationships to Disclose
 
Bruno Chauffert
No Relationships to Disclose
 
Olivier Mir
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; GlaxoSmithKline; Novartis; Pfizer; PharmaMar; Roche